参考文献/References:
［1］ House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution［J］. J Am Coll Surg, 2010, 210: 744- 752.
［2］ Lencioni R, Llovet JM. Modified RECIST （mRECIST） assessment for hepatocellular carcinoma［J］. Semin Liver Dis, 2010, 30: 52- 60.
［3］ Sotelo MJ, Garcia- Paredes B, Aguado C, et al. Role of cetuximab in first- line treatment of metastatic colorectal cancer［J］. World J Gastroenterol, 2014, 20: 4208- 4219.
［4］ 全 毅， 何柱光， 李祥厦． TACE治疗化疗后进展期结直肠癌肝转移的临床研究［J］． 重庆医学， 2012， 41： 859- 860．
［5］ Fiorentini G, Aliberti C, Mulazzani LA, et al. Chemoembolization in colorectal liver metastases： the rebirth［J］. Anticancer Res, 2014, 34: 575- 584.
［6］ 范卫君， 张 亮， 顾仰葵， 等． 大肠癌肝转移的射频消融治疗［J］． 介入放射学杂志， 2006， 15： 75- 77．
［7］ 王建华， 王小林． 腹部介入放射学［M］． 上海： 上海医科大学出版社， 1998．
［8］ 邵子力， 吴 健， 陈敏山， 等． 射频消融与手术切除治疗结直肠癌肝转移的疗效比较［J］． 广东医学， 2012， 33： 1410- 1413．
［9］ 孙崇启， 赵 静． 射频消融技术临床应用现状［J］． 介入放射学杂志， 2007， 16： 502- 504．
［10］ Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non- resectable colorectal liver metastases: a rando- mized EORTC Intergroup phase Ⅱ study （EORTC 40004）［J］. Ann Oncol, 2012, 23: 2619- 2626.
［11］ Ruers T, Coevorden F van, Pierie J, et al. Radiofrequency ablation （RFA） combined with chemotherapy for unresectable colorectal liver metastases （CRC LM）: interim results of a randomised phase Ⅱ study of the EORTC- NCRI CCSG- ALM Intergroup 40004（CLOCC）［J］. J Clin Oncol （Meeting Abstracts）, 2008, 26: 4012.
［12］ 赵 明， 王健鹏， 吴沛宏， 等． 射频消融治疗结直肠癌肝转移及其预后因素分析［J］． 中华医学杂志， 2010， 90： 1587- 1592．
［13］ Di Bartolomeo M, Maggi C, Ricchini F, et al. Bevacizumab treatment in the elderly patient with metastatic colorectal cancer［J］. Clin Interv Aging, 2015, 10: 127- 133.
［14］ Heinemann V, Von Weikersthal LF, Decker T, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first- line treatment for patients with metastatic colorectal cancer （FIRE- 3）: a rando- mised, open- label, phase 3 trial［J］. Lancet Oncol, 2014, 15: 1065- 1075.
相似文献/References:
[1]蒲红.上海市第二届射频消融疑难病例研讨会纪要[J].介入放射学杂志,1997,(01):63.
[2]蒲红,尹炯,王咏梅,等.显性间隔房室旁路的射频消融[J].介入放射学杂志,1997,(02):104.
[3]罗荣光,黄金华.肿瘤射频消融：电极的类型和消融灶的特点[J].介入放射学杂志,2011,(02):159.
LUO Rong-guang,HUANG Jin-hua..Radiofrequency ablation of tumors: the relationship between the electrode type and the feature of ablated zone[J].journal interventional radiology,2011,(02):159.
[4]朱先海,吕维富,鲁 东,等.超选择性肾动脉栓塞术联合射频消融治疗肾癌的临床应用[J].介入放射学杂志,2011,(07):541.
ZHU Xian-hai,LV Wei-fu,LU Dong,et al.Superselective renal artery embolization combined with radiofrequency ablation for the treatment of renal carcinomas: evaluation of clinical results[J].journal interventional radiology,2011,(02):541.
[5]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合１２５Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(02):863.
[6]李建军,郑加生,崔雄伟,等. 肝肿瘤CT引导经皮射频消融术后胆道并发症防治[J].介入放射学杂志,2011,(12):984.
LI Jian-jun,ZHENG Jia-sheng,CUI Xiong-wei,et al.The prevention and treatment of biliary complications occurred after CT-guided percutaneous radiofrequency ablation for hepatic neoplasms[J].journal interventional radiology,2011,(02):984.
[7]程洪涛,郭晨阳,黎海亮,等.ＴＡＣＥ联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ＣＴｇｕｉｄｅｄ ｐｅｒｃｕｔａｎｅｏｕｓ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａｎ ａｎａｌｙｓｉｓ ｏｆ ｆａｃｔｏｒｓ ａｆｆｅｃｔｉｎｇ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｒｅｓｕｌｔ [J].journal interventional radiology,2012,(02):216.
[8]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合ＣＴ引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
,,et al.Ｓｅｑｕｅｎｔｉａｌ ｔｒｅａｔｍｅｎｔ ｗｉｔｈ ＴＡＣＥ ａｎｄ ＣＴｇｕｉｄｅｄ ＲＦＡ ｆｏｒ ｓｍａｌｌ ａｎｄ ｍｏｄｅｒａｔｅ ｓｉｚｅｄ ＨＣＣ [J].journal interventional radiology,2012,(02):301.
[9]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(02):322.
[10]王 会,胡继红,赵 卫. 骨肿瘤的消融治疗[J].介入放射学杂志,2012,(10):879.
WANG Hui,HU Ji- hong,ZHAO Wei.. Recent advances in ablation therapy of bone neoplasm[J].journal interventional radiology,2012,(02):879.